Aclaris Therapeutics, Inc.ACRSNASDAQ
Loading
Cash generated from core business operations
Latest
$-47.11M
↑ 20% vs avg
Percentile
P50
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-59.04M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $-47.11M | -134.7% |
| 2024 | $-20.07M | +74.4% |
| 2023 | $-78.33M | -15.9% |
| 2022 | $-67.57M | -29.6% |
| 2021 | $-52.13M | -34.9% |
| 2020 | $-38.63M | +59.9% |
| 2019 | $-96.44M | +4.3% |
| 2018 | $-100.81M | -84.4% |
| 2017 | $-54.66M | -58.0% |
| 2016 | $-34.60M | - |